@article{6b0900aee6054c268a74abe0d27619c0,
title = "Fragile X Mental Retardation Protein expression in the retina is regulated by light",
abstract = "Fragile X Mental Retardation Protein (FMRP) is a RNA-binding protein that modulates protein synthesis at the synapse and its function is regulated by glutamate. The retina is the first structure that participates in vision, and uses glutamate to transduce electromagnetic signals from light to electrochemical signals to neurons. FMRP has been previously detected in the retina, but its localization has not been studied yet. In this work, our objectives were to describe the localization of FMRP in the retina, to determine whether different exposure to dark or light stimulus alters FMRP expression in the retina, and to compare the pattern in two different species, the mouse and chick. We found that both FMRP mRNA and protein are expressed in the retina. By immunohistochemistry analysis we found that both mouse and chick present similar FMRP expression localized mainly in both plexiform layers and the inner retina. It was also observed that FMRP is down-regulated by 24 h dark adaptation compared to its expression in the retina of animals that were exposed to light for 1 h after 24 h in the dark. We conclude that FMRP is likely to participate in retinal physiology, since its expression changes with light exposure. In addition, the expression pattern and regulation by light of FMRP seems well conserved since it was similar in both mouse and chick.",
keywords = "FMRP, MGluR, Metabotropic glutamate receptor, Plasticity, Vision",
author = "Guimar{\~a}es-Souza, {E. M.} and O. Perche and Morgans, {C. W.} and Duvoisin, {R. M.} and Calaza, {K. C.}",
note = "Funding Information: We thank Dr. Kimberly Huber for the 2F5 antibody and helpful discussions. We thank Tammie Haley and Sarah Rodrigues for the technical support. E. M. Guimar{\~a}es-Souza received a scholarship from the program “Ci{\^e}ncia sem Fronteiras”, by Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecnol{\'o}gico (CNPq, protocol number 245861/2012-2 ) to perform experiments abroad, and a regular PhD scholarship in Brazil by Coordena{\c c}{\~a}o de Aperfei{\c c}oamento de Pessoal de Ensino Superior (CAPES). KCC is a research fellow of CNPq. This research was supported by NIH grants EY09534 (RMD), EY022369 (CWM), CNPq, CAPES , FAPERJ and PRONEX/MCT . Fmr1 KO investigation was supported by CNRS, Regional Hospital of Orl{\'e}ans, University of Orl{\'e}ans, FEDER 35106 grant, and FRAXA Research Foundation (USA) grant (2015–2016). Funding Information: We thank Dr. Kimberly Huber for the 2F5 antibody and helpful discussions. We thank Tammie Haley and Sarah Rodrigues for the technical support. E. M. Guimar{\~a}es-Souza received a scholarship from the program “Ci{\^e}ncia sem Fronteiras”, by Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecno{\'o}gico (CNPq, protocol number 245861/2012-2) to perform experiments abroad, and a regular PhD scholarship in Brazil by Coordena{\c c}{\~a}o de Aperfei{\c c}oamento de Pessoal de Ensino Superior (CAPES). KCC is a research fellow of CNPq. This research was supported by NIH grants EY09534 (RMD), EY022369 (CWM), CNPq, CAPES, FAPERJ and PRONEX/MCT. Fmr1 KO investigation was supported by CNRS, Regional Hospital of Orleans, University of Orleans, FEDER 35106 grant, and FRAXA Research Foundation (USA) grant (2015e2016). Publisher Copyright: {\textcopyright} 2015 Elsevier Ltd.",
year = "2016",
month = may,
day = "1",
doi = "10.1016/j.exer.2015.11.025",
language = "English (US)",
volume = "146",
pages = "72--82",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
}